Association between existence of integrons and multi-drug resistance in Acinetobacter isolated from patients in Southern Iran

Polish Journal of Microbiology

Volumn 60, Issue 2, 2011, Pages 163-168

  Japoni, Sara ^a   Japoni, Aziz ^b   Farshad, Shoreh ^b   Ali, Ahya Abdi ^a   Jamalidoust, Marzieh ^b  

^a ALZAHRA UNIVERSITY   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acinetobacter; Integrons; Multi drug resistance; PCR assay

Indexed keywords

AMIKACIN; AMPICILLIN; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; INTEGRASE; MEROPENEM; NORFLOXACIN; SULBACTAM; TOBRAMYCIN;

ACINETOBACTER; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; EPSILOMETER TEST; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INTEGRON; IRAN; MULTIDRUG RESISTANCE; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; SHORT SURVEY; TRANSPOSON;

ACINETOBACTER;

EID: 80054909191     PISSN: 17331331     EISSN: None     Source Type: Journal    
DOI: 10.33073/pjm-2011-023     Document Type: Short Survey

References (24)

1. Arakawa Y., M. Murakami, K. Suzuki, H. Ito, R. Wacharotayankun, S. Ohsuka, N. Kato and M. Ohta, M. 1995. A novel integron-like element carrying the metallo-b-lactamase gene blaIMP. Antimicrob. Agents. Chemother. 39: 1612-1615.
2. Bergogne-Berezin E. and K.J. Towner. 1996. Acinetobacter spp. as nosocomial pathogens: Microbiological, clinical & epidemiological features. Clin. Microbiol. 8: 148-165. (Pubitemid 26123943)
3. Chen T.L., W.C. Chang, S.C. Kuo, Y.T. Lee, C.P. Chen, L.K. Siu, W.L. Cho and C.P. Fung. 2010. Contribution of a plasmid borne blaOXA-58 with its hybrid promoter provided by IS1006 and ISAba3-like to {beta}-lactam resistance in Acinetobacter genomic species 13TU. Antimicrob. Agents. Chemother. 54: 3107-3112.
4. Feizabadi M.M., B. fatollahzadeh, M. Taherikalani, M. Rasoolinejad, N. Sadeghiferd, M. Aligholi, S. Soroush and S. Mohammadi- Yegane. 2008. Antimicrobial susceptibility patterns and distribution of bla OXA genes among Acinetobacter spp. isolated from patients at Tehran hospitals. Jpn. J. Infect. Dis. 61: 274-278.
5. Galleco L. and K.J Towner. 2001. Carriage of class 1 integrons and antibiotic resistance in clinical isolates of Acinetobacter baumannii from Northern Spain. J. Med. Microbiol. 50: 71-77. (Pubitemid 32042809)
6. Gaur A., P. Prakash, S. Anupurba and T.M. Mahapatra. 2006. Possible role of integrase gene polymerase chain reaction as an epidemiological marker: study of multi-drug resistant Acinetobacter baumannii isolated from nosocomial infections. Int. J. Antimicrobial. Agents. 29: 446-450. (Pubitemid 46357608)
7. Gisneous J.M. and J. Rodriguez-Bano. 2002. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin. Microbiol. Infects. 8: 687-693. (Pubitemid 35385864)
8. Gonzalez G., K. Sossa, H. Bello, M. Dominguez, S. Mella and R. Zemelman. 1998. Presence of integrons in isolates of different biotypes of Acinetobacter baumannii from Chilean hospitals. FEMs. Microbiol. lett. 161: 125-128. (Pubitemid 28161324)
9. Koeleman J.G., J. Stoof, M.W. Van Der bijl, C. M.Vandenbroucke- Grauls and P.H. Savelkoul. 2000. Identification of epidemic strains of Acinetobacter baumannii by integrase gene PCR. J. Clin. Microbiol. 39: 8-13. (Pubitemid 32059560)
10. Lévesque C., L. Piché, C. Larose and P.H. Roy. 1995. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob. Agents. Chemother. 39: 185-91.
11. Lewis J.R. and S.A. Lewis. 2004. Colistin interactions with mammalian urothelium. Am. J. physiol. Cell. physiol. 286: C913-C922.
12. Neild B.S., A.J. Holmes, M.R. Gillings, G.D. Recchia, B.C. Mabbutt, K.M. Nevalainen and H.W. Stokes. 2001. Recovery of new integron classes from environmental DNA. FEMS. Microbiol. Lett. 195: 59-65. (Pubitemid 32146536)
13. Nordmann P. 2004. Acinetobacter baumannii, the nosocomial pathogen par excellence. Pathol. Biol. 52: 301-303. (Pubitemid 38916887)
14. Perez F., A.M. Hujer, K.M. Hujer, B.K. Decker, P.N. Rather and R.A. Bonomo. 2007. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents. Chemother. 51: 3471-3484. (Pubitemid 47519332)
15. Ploy M.C., F. Denis, P. Courvalin and T. Lambert. 2000. Molecular characterization of integrons in Acinetobacter baumannii: description of a hybrid class 2 integron. Antimicrob. Agents. Chemother. 44: 2684-2688.
16. Radström P., O. Sköld, G. Swedberg, J. Flensburg, P.H. Roy and L. Sundström. 1994. Transposon Tn5090 of plasmid R751, which carries an integron, is related to Tn7, Mu, and the retroelements. J. Bacteriol. 176: 3257-3268. (Pubitemid 24166717)
17. Reed M.D., R.C. Stern, M.A. O'Riordan and J.L. Blumer. 2001. The pharmacokinetics of colistin in patients with cystic fibrosis. J. Clin. Pharmacol. 41: 645-54. (Pubitemid 32493359)
18. Rowe-Magnus D. A. and D. Mazel. 1999. Resistance gene capture. Curr. Opin. Microbiol. 2: 481-486.
19. Seifert H., R. Baginsky, A. Schulze and G. Polverer. 1993. The distribution of Acinetobacter species in clinical culture materials. Zentralbl. Bakteriol. 279: 544-552. (Pubitemid 2004863)
20. Seward R.J. 1999. Detection of integrons in worldwide nosocomial isolates of Acinetobacter spp. Clin. Microbiol. Infect. 5: 308-318. (Pubitemid 29312608)
21. Towner K.J. 2009. Acinetobacter: an old friend, but a new enemy. J. Hosp. Infect. 73: 355-63.
22. Turton J.F., M.E. Kaufmann, J. Glover, J.M. Coelho, M. Warner, R. Pike and T.L. Pitt. 2005. Detection and typing of integrons in epidemic strains of Acinetobacter baumannii found in the United Kingdom. J. Clin. Microbiol. 43: 3074-3082. (Pubitemid 40981305)
23. Villegas M.V. and A.I. Hartstein. 2003. Acinetobacter outbreaks, 1977-2000. Infect. Control. Hosp. Epidemiol. 24: 284-95. (Pubitemid 36538142)
24. Xu X., F. Kong, X. Cheng, B. Yan X. Du, J. Gai, H.Ai, L. Shi and J. Iredell. 2008. Integron gene Cassettes in Acinetobacter spp. Strains from south China". Int. J. Antimicrobial. Agents. 32: 441-445.